FDA Approved: LITHOSTAT — Supplemental Application (Mission Pharmacal Company)

View source ↗

Summary

FDA approves a supplemental application for Lithostat (acetohydroxamic acid) submitted by Mission Pharmacal Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Drugs mentioned

• LITHOSTAT (acetohydroxamic acid)

Snippet

SUPPL AP for LITHOSTAT (ACETOHYDROXAMIC ACID)